GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in adults with anaemia. Ojjaara is…
Atopic eczema is an allergic skin condition that not only affects the skin but also plays a central role in various other health issues. It impacts mental health and leads to the development of other diseases. The disease is incredibly…
The new partnerships bring its total contributions to JPY 24.2 billion (Approx. USD 167.5 million) across 29 long-term partnerships. Takeda’s workforce is an integral part of the annual decision-making process as over 24,500 purpose-led employees participated in the selection of…
With cancer patients top of mind, teams of Bristol Myers Squibb employees will celebrate a decade of Coast 2 Coast 4 Cancer (C2C4C) this year and cycle nearly 3,000 miles from Oregon to New Jersey with the goal of raising…
World Brain Day (WBD), first launched in 2014, is an annual event observed on July 22, aimed at promoting awareness and education for neurological disorders that affect individuals worldwide. Every year, the World Federation of Neurology sets a different theme…
Needs Map is a social cooperative that brings people in need together with individuals and organizations who seek to lend a helping hand. Ever since the earthquake in Turkey, the non-profit has provided aid and support where it is most…
In fact, up to 50% of health outcomes are determined by behavior. By establishing the Behavioral Science Consortium (BSC), Astellas is recognizing the importance of human behavior for patient outcomes and committing to using behavioral science to improve them. The…